We believe definition

We believe. RPI has developed novel technology that may offer a potential breakthrough for the treatment of Hepatitis C," said Xxxx X. Xxxxxxx, Ph.D.,vice president of infectious diseases discovery research and clinical investigation for Lilly. "Our collaboration with RPI gives us an opportunity to further expand our efforts in this important medical area."
We believe we operate one of the largest repair and refurbishment networks in North America..." Exhibit D Form of Lock-Up Agreement May 17, 2006 Bear, Xxxxxxx & Co. Inc. Banc of America Securities LLC c/o Bear, Xxxxxxx & Co. Inc. 000 Xxxxxxx Xxxxxx Xxx Xxxx, Xxx Xxxx 00000 Attention: Equity Capital Markets The Greenbrier Companies, Inc. Lock-Up Agreement Ladies and Gentlemen: This letter agreement (this "Agreement") relates to the proposed offering (the "Offering") by The Greenbrier Companies, Inc., an Oregon corporation (the "Company"), of its 2.375% Convertible Senior Notes due 2026 (the "Notes") in an aggregate principal amount of up to $100 million (including the Initial Purchasers' over-allotment option). In order to induce you (the "Initial Purchasers") to purchase Notes in the Offering, the undersigned hereby agrees that, without the prior written consent of Bear, Xxxxxxx & Co. Inc. ("Bear Xxxxxxx"), during the period from the date hereof until sixty (60) days from the date of the final offering memorandum for the Offering (the "Lock-Up Period"), the undersigned (a) will not, directly or indirectly, offer, sell, agree to offer or sell, solicit offers to purchase, grant any call option or purchase any put option with respect to, pledge, borrow or otherwise dispose of any Relevant Security (as defined below), and (b) will not establish or increase any "put equivalent position" or liquidate or decrease any "call equivalent position" with respect to any Relevant Security (in each case within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder), or otherwise enter into any swap, derivative or other transaction or arrangement that transfers to another, in whole or in part, any economic consequence of ownership of a Relevant Security, whether or not such transaction is to be settled by delivery of Relevant Securities, other securities, cash or other consideration; provided, however, that the foregoing restrictions shall not preclude or otherwise limit (i) the transfer to the Company of common stock of the Company, no par value ("Common Stock"), in connection with the exercise of outstanding options to purchase that are scheduled to expire during the 60-day period solely to pay the option exercise price or any taxes required to be withheld by the Company to the extent such transfer is permitted to satisfy such obligations pursuant to the Company's equity compensation plans or the agreements...
We believe. RPI has developed novel technology that may offer a potential breakthrough for the treatment of Hepatitis C," said Xxxx X. Xxxxxxx, Ph.D.,vice president of infectious diseases discovery research and clinical investigation for Lilly. "Our collaboration with RPI gives us an opportunity to further expand our efforts in this important medical area." "We look forward to collaborating with Lilly in the development of novel therapeutics to treat HCV. The recent results with HEPTAZYME are very encouraging and take us one step closer to providing an effective treatment for the HCV," said Xx. Xxxxx Xxxxxxxxxxxxxx, Ph.D., Chief Executive Officer and President of RPI. Lilly is a global research-based pharmaceutical corporation headquartered in Indianapolis, Indiana, that is dedicated to creating and delivering innovative pharmaceutical based health care solutions which enable people to live longer, healthier, and more active lives. RPI, located in Boulder, Colorado, was founded to capitalize on the broad potential of ribozymes for use as human therapeutics and other areas, including the identification of gene function and therapeutic target validation. RPI is also developing an anti-angiogenesis compound ANGIOZYME(TM) in collaboration with Chiron Corporation. ANGIOZYME is in Phase I clinical trials. This release may contain forward-looking statements that reflect management's current views of future events and operations. The information is based on management's current expectations but actual results may differ materially due to various factors, including those mentioned in this release, risks and uncertainties, including market conditions, competitive pricing, the successful outcome of clinical trials, the timely receipt of regulatory approvals and those outlined in Lilly and RPI filings with the SEC. [ * ] Confidential treatment requested XXXXXXXX X MANUFACTURING RESPONSIBILITIES DOCUMENT (MRD) TABLE OF CONTENTS GUIDELINE (Bulk Drug Substance)

Examples of We believe in a sentence

  • We believe that our audits provide a reasonable basis for our opinion.

  • We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.

  • We believe that our audit provides a reasonable basis for our opinion.

  • We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

  • We believe that our examination provides a reasonable basis for our opinion.

  • We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinions.

  • We believe that the evidence obtained provides a reasonable basis for our findings and conclusions based on our audit objectives.

  • We believe that the evidence we obtained is sufficient and appropriate to provide a reasonable basis for our opinion.

  • We believe that our audits provide a reasonable basis for the opinion expressed above.

  • We believe that the evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.


More Definitions of We believe

We believe xxxxx xx xxxxxxxxxxx xpportunity for this unique dose combination to contribute to pain management and this agreement allows us to bring this product to market at least 12 months earlier than expected. This acquisition will be accretive following the launch of the product, and this unique Darvocet(TM) line extension will be one of the key drivers of near-term growth for aaiPharma's pain management offering." The total propoxyphene market, generic and branded, is valued at more than $500 million, according to 2002 Verispan data. This new, unique Darvocet(TM) line extension is expected to add substantial value to aaiPharma's growing portfolio of branded pain management products. Separate from this acquisition, aaiPharma plans to launch another Darvon(R) line extension later this year, in addition to the launch of Darvon(R) Compound 32, which was announced in June 2003. ABOUT AAIPHARMA --------------- aaiPharma Inc. is a leading, science-based specialty pharmaceutical company with corporate headquarters in Wilmington, North Carolina. With more than 23 years of drug development expertise and a proven sales and marketing track record, the Company is focused on acquiring, improving and marketing well-known, branded medicines in pain management, gastroenterology and critical care. In addition to its branded product portfolio and robust pipeline, aaiPharma continues to offer comprehensive drug development services to the pharmaceutical, biotechnology, generic and device industries through its services division, AAI Development Services. For more information, please visit aaiPharma's website at www.aaipharma.com.
We believe school choice” means giving greater funding to schools that commit to being inclusive, affordable and accessible, so that more families can chose them.
We believe issuers will benefit by participating in this settlement program because it offers an immediate recovery with respect to losses they may have incurred from the Heartland intrusion,” said Xxxxx Xxxxxx, chief enterprise risk officer, Visa Inc. “Helping financial institutions mitigate costs after a data security breach has been a long-standing component of Visa’s security strategy, along with promoting new security technologies, preventing fraud and leading efforts to secure sensitive data across the entire payment system.”

Related to We believe

  • believe guidance," "estimate," "intend," predict," and "continue" or similar words or any connection with any discussion of future events or circumstances or of management's current estimates or beliefs. Forward-looking statements are subject to risks and uncertainties, and therefore results may differ materially from those set forth in those statements. A transaction as contemplated would require approvals of the Boards of Directors and shareholders of both parties and numerous other conditions. Full details of such a transaction will be provided to DPAC shareholders and filed with the SEC by DPAC as and when appropriate. There is no assurance possible, and none is intended, that the transaction will be completed at all or on the terms described. The transaction is and shall continue to be subject to certain conditions and contingencies until the transaction is completed. DPAC Technologies Corp. will provide further detailed information to its shareholder as and when required to solicit their consent. The transaction's costs and diversion of management attention could negatively impact results. The recent delisting of our shares could continue to have adverse effects on the liquidity of trading in the common stock and the price per share. Other factors that affect DPAC's business and its ability to conclude a merger transaction include, but are not limited to, that our Airborne(TM) products are new, that we sell to original equipment manufacturers for new product introductions by them, and that all of these are subject to risks and uncertainties regarding new product introductions such as uncertainty of market acceptance. The parties need additional financing to complete the transactions as envisioned. Such financing may not be available on favorable terms, and if available may result in issuance of warrants and additional dilution to holders of DPAC common stock. Also, there can be no assurance that such transaction will be completed or, if completed, that it will be successful. The transaction would involve a change of control, in that voting control of DPAC would be transferred to a former principal shareholder of QuaTech. Other factors that affect DPAC's business include, but are not limited to, the degree of market acceptance of our existing and planned wireless connectivity products, future business opportunities with these products, protection of licensed technology or proprietary rights, risks of litigation, our need for additional financing in order to realize our opportunities, other challenges related to completing our proposed merger with QuaTech, Inc., further challenges in subsequently combining our operations with QuaTech, Inc.'s own, and general market and economic conditions. More information about the risks and challenges faced by DPAC Technologies Corp. is contained in the Securities and Exchange Commission filings made by the Company on Form 10-K, 10-Q and 8-K. DPAC Technologies Corp. specifically disclaims any obligation to update or revise any forward-looking statements whether as a result of new information, future developments or otherwise.

  • Threatening behavior means any pattern of behavior or isolated action, whether or not it is directed at another person, that a reasonable person would believe indicates potential for future harm to students, school personnel, or school property.

  • Lead means Lead and Lead Compounds.

  • believes “expects”, “aims”, “intends”, “will”, “may”, “shall”, “should”, “anticipates”, “estimates”, “projects”, “is subject to”, “budget”, “scheduled”, “forecast” or words or terms of similar substance or the negative thereof, are forward looking statements. Forward looking statements include statements relating to the following: (i) future capital expenditures, expenses, revenues, earnings, synergies, economic performance, indebtedness, financial condition, dividend policy, losses and future prospects; (ii) business and management strategies and the expansion and growth of Bidco’s or Xxxx Xxxxx’x operations and potential synergies resulting from the Acquisition; and (iii) the effects of government regulation on Bidco’s or Xxxx Xxxxx’x business. Such forward looking statements are prospective in nature and are not based on historical facts, but rather on current expectations and projections of the management of Bidco and Xxxx Xxxxx about future events, and are therefore subject to risks and uncertainties that could significantly affect expected results and are based on certain key assumptions. Many factors could cause actual results to differ materially from those projected or implied in any forward looking statements, including: increased competition, the loss of or damage to one or more key customer relationships, changes to customer ordering patterns, delays in obtaining customer approvals for engineering or price level changes, the failure of one or more key suppliers, the outcome of business or industry restructuring, the outcome of any litigation, changes in economic conditions, currency fluctuations, changes in interest and tax rates, changes in raw material or energy market prices, changes in laws, regulations or regulatory policies, developments in legal or public policy doctrines, technological developments, the failure to retain key management, or the timing and success of future acquisition opportunities or major investment projects. Other unknown or unpredictable factors could cause actual results to differ materially from those in the forward looking statements. Such forward looking statements should therefore be construed in the light of such factors. Neither Bidco nor Xxxx Xxxxx, nor any of their respective associates or directors, officers or advisers, provides any representation, assurance or guarantee that the occurrence of the events expressed or implied in any forward looking statements in this Announcement will actually occur. Due to such uncertainties and risks, readers are cautioned not to place undue reliance on such forward looking statements, which speak only as of the date hereof. All subsequent oral or written forward looking statements attributable to any member of the Bidco Group or the Xxxx Xxxxx Group, or any of their respective associates, directors, officers, employees or advisers, are expressly qualified in their entirety by the cautionary statement above. Bidco and Xxxx Xxxxx expressly disclaim any obligation to update any forward looking or other statements contained herein, except as required by applicable law or by the rules of any competent regulatory authority, whether as a result of new information, future events or otherwise.

  • Positive Behavioral Theory and Practice means a proactive approach to individual behavior and behavior interventions that:

  • Advise means the act of sending an Advice from Broker.

  • Intimidating, threatening, abusive, or harming conduct means, but is not limited to, conduct that does the following:

  • Mistletoe Thinning means the removal of designated conifer trees bearing visible mistletoe plants on branches as well as visible plants or infections on the stem.

  • Life-threatening means that the subject was at immediate risk of death from the AE as it occurred or it is suspected that use or continued use of the product would result in the subject’s death. ‘Life-threatening’ does not mean that had an AE occurred in a more severe form it might have caused death (eg, hepatitis that resolved without hepatic failure).

  • Socially and economically disadvantaged person means an individual who is a citizen or lawful permanent resident of the United States and who is Black, Hispanic, Native American, Asian, Female; or a member of another group or an individual found to be disadvantaged by the Small Business Administration pursuant to Section 3 of the Small Business Act.

  • Takaful means a scheme based on brotherhood, solidarity and mutual assistance which provides for mutual financial aid and assistance to the Takaful Participants in case of need whereby the Takaful Participants mutually agree to contribute for that purpose.

  • the Company’s knowledge means the knowledge, after reasonable inquiry, of Pxxxxx Xxxxx, Lxxxxxxx Xxxxxx, Sxxxxxx XxXxxxxx and Kxxxxxx Xxxxx.

  • Overissue means the purported issuance of:

  • Material Financial Relationship means a relationship in which one person is a recipient of any kind of payment such as by way of a loan or gift during the immediately preceding twelve months, equivalent to at least 25% of such payer’s annual income but shall exclude relationships in which the payment is based on arm’s length transactions.

  • REASONABLY SAFE FROM FLOODING Means base flood waters will not inundate the land or damage structures to be removed from the floodplain and that any subsurface waters related to the base flood will not damage existing or proposed buildings.

  • Credible threat means a verbal or nonverbal threat, or a combination of the two, including threats delivered by electronic communication or implied by a pattern of conduct, which places the person who is the target of the threat in reasonable fear for his or her safety or the safety of his or her family members or individuals closely associated with the person, and which is made with the apparent ability to carry out the threat to cause such harm. It is not necessary to prove that the person making the threat had the intent to actually carry out the threat. The present incarceration of the person making the threat is not a bar to prosecution under this section.

  • We Are Committed To Your Satisfaction If you are not completely satisfied with XOOM’s Variable Rate plan for any reason, please contact us. If we are unable to resolve your concern to your full satisfaction, you may terminate this Contract, in accordance with its terms.

  • Suspect means the person or persons against or in relation to whom an inquiry is initiated in case of leak or suspected leak of UPSI.

  • External dose means that portion of the dose equivalent received from any source of radiation outside the body.

  • Non-Participating Certified Nurse Practitioner means a Certified Nurse Practitioner who does not have a written agreement with the Claim Administrator or another Blue Cross and/or Blue Shield Plan to provide services to you at the time services are rendered.

  • Negligent treatment or maltreatment means an act or a

  • As low as is reasonably achievable (ALARA) means making every reasonable effort to maintain exposures to radiation as far below the dose limits in these regulations as is practical, consistent with the purpose for which the licensed or registered activity is undertaken, taking into account the state of technology, the economics of improvements in relation to state of technology, the economics of improvements in relation to benefits to the public health and safety, and other societal and socioeconomic considerations, and in relation to utilization of nuclear energy and licensed or registered sources of radiation in the public interest.

  • Notify means to provide a Notice.

  • Certified nurse practitioner means an individual who is licensed as a registered professional nurse under part 172 who has been granted a specialty certification as a nurse practitioner by the Michigan board of nursing under section 17210.

  • Reasonable grounds means that a reasonable person in your position would also suspect the information indicates misconduct or a breach of the law.

  • Larceny or Embezzlement means larceny or embezzlement as defined in Section 37 of the Investment Company Act of 1940.